Author:
Katdare Ninad,Bhatt Aditi,Glehen Olivier
Reference231 articles.
1. Glehen O, Gilly FN, Boutitie F, et al. Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with peri-operative intraperitoneal chemotherapy: a multi-institutional study of 1,290 patients. Cancer. 2010;116(24):5608–18.
2. Saxena A, Valle SJ, Liauw W, Morris DL. Recurrence and survival outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for small bowel adenocarcinoma. Anticancer Res. 2017;37(10):5737–42.
3. Jacquet P, Sugarbaker PH. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res. 1996;82:359–74.
4. Karunasena E, Sham J, McMahon KW, Ahuja N. Genomics of peritoneal malignancies. Surg Oncol Clin N Am. 2018;27(3):463–75. https://doi.org/10.1016/j.soc.2018.02.004.
5. Strimbu K, Tavel JA. What are biomarkers? Curr Opin HIV AIDS. 2010;5(6):463–6. https://doi.org/10.1097/COH.0b013e32833ed177.